Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration-resistant prostate cancer: Real-world experience in the Southeast Asian cohort

• Main Authors: Lim, Jasmine, Amantakul, Akara, Shariff, Nisha, Lojanapiwat, Bannakij, Alip, Adlinda, Ong, Teng Aik, Thevarajah, Shankaran, Ahmayuddin, Firdaus, Mathew, Adeline, Sriplakich, Supon, Vuthiwong, Jaraspong, Chong, Flora Li Tze, Saad, Marniza
• Format: Article
• Published: Wiley Open Access 2020
• Subjects: RD Surgery
• Online Access: http://eprints.um.edu.my/36695/
• Institution: Universiti Malaya

It is of much interest to understand the efficacy of abiraterone acetate (AA) in routine clinical practice. We assessed the clinical outcome of AA in patients with metastatic castration-resistant prostate cancer (mCRPC) and determined clinical factors associated with AA treatment duration in real-wo...